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Nucleosome distortion as a possible 
mechanism of transcription activation domain 
function
Tamara Y. Erkina and Alexandre M. Erkine*
Abstract 
After more than three decades since the discovery of transcription activation domains (ADs) in gene-specific activa-
tors, the mechanism of their function remains enigmatic. The widely accepted model of direct recruitment by ADs 
of co-activators and basal transcriptional machinery components, however, is not always compatible with the short 
size yet very high degree of sequence randomness and intrinsic structural disorder of natural and synthetic ADs. In 
this review, we formulate the basis for an alternative and complementary model, whereby sequence randomness and 
intrinsic structural disorder of ADs are necessary for transient distorting interactions with promoter nucleosomes, trig-
gering promoter nucleosome translocation and subsequently gene activation.
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Background
Transcriptional activators are the main triggers of gene 
activation, determining not only the specific selection 
of genes transcribed in response to distinct stimuli, but 
also the level of transcription and its modulation [1–4]. 
A typical activator molecule consists of at least two criti-
cal parts: a DNA-binding domain (DBD), which deter-
mines specificity of binding to a distinct promoter DNA 
sequence, and a transcription activation domain (AD), 
which determines initiation of transcription and its level. 
Additional domains responsible for oligomerization, 
cellular localization, degradation, and other functions 
vary greatly between activators. DNA-binding domains 
are well characterized both by specificity of promoter 
sequence recognition and by distinct structural features 
[5–7]; ADs, however, despite being discovered more 
than three decades ago, remain largely enigmatic [3, 8]. 
Although the broadly accepted mechanism of ADs’ action 
involves direct physical recruitment of a wide variety of 
enzymatic activities and protein complexes associated 
with chromatin remodeling and transcription initiation, 
the order of recruitment events, structural determinants, 
and specific amino acid sequences involved in recruit-
ment events are often not clear and/or are contradictory.
The growing number of human diseases associated with 
the malfunction of gene expression argues for the develop-
ment of new drugs affecting specific transcriptional acti-
vators or functionally substituting them [9–11]. Technical 
capabilities for small-molecule artificial activators have 
been demonstrated by a chemical synthesis of both func-
tional DBDs [7, 9, 12] and ADs [13, 14]. Nevertheless, the 
development of artificial activators with specific transcrip-
tion activation potential is greatly hampered by deficien-
cies in our understanding of mechanisms of ADs’ function, 
which have been documented by different researchers over 
the past two decades [3, 8, 15, 16]. Thus, elucidation of 
ADs’ functional mechanism is critically important for dif-
ferent areas of molecular biology and medicine.
Review
ADs’ properties and characteristics
Interchangeability of ADs
One of the remarkable properties of ADs is the gen-
eral functional interchangeability among gene-specific 
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activators. Testing all 6000 ORFs of the yeast genome for 
functionality as activators in the context of Gal4 DBD, 
and GAL1-HIS3 and GAL1-LacZ reporters revealed that 
92 known yeast activators can work in this new context, 
with 32 showing strong activation potential [17]. This 
functional conservation and ease of functional inter-
changeability are not restricted to a particular intracel-
lular environment. Moreover, such interchangeability is 
also easily observed for transcriptional activators belong-
ing to such widely diverse phyla as mammals, fungi, and 
plants. The most vivid examples are such ADs as VP16 
(derived from herpes simplex virus protein Vmw65), 
yeast Gal4 AD (used in variety of two-hybrid screening 
systems), and human p53 AD [1, 18–22].
Absence of structural and sequence conservation among ADs
Based on the ease of interchangeability, it is logical to 
expect some similarities in structure and/or sequence 
composition. Contrary to these expectations, compari-
son of the amino acid sequences of known ADs does 
not reveal any amino acid consensus or specific struc-
tural motif. In fact, the majority of known natural ADs 
have no distinct structure and are characterized by a 
high level of intrinsic disorder [23, 24]. Despite being so 
widely diverse, ADs can be divided with some approxi-
mation into different categories based on their composi-
tion: acidic, glutamine-rich, and proline-rich [25], with 
the former type being the most abundantly represented 
in higher eukaryotes and nearly the only type found in 
yeast.
ADs amino acid composition
Over the years, there have been several attempts to gain 
insight into ADs’ composition and other characteristics 
using a yeast one-hybrid fusion protein system, whereby 
random sequences were screened for functionality as 
ADs while connected to a variety of DBDs using a viabil-
ity test based on a single reporter. The pioneering screen 
was done by Ma and Ptashne in 1987, testing randomly 
fragmented E. coli genomic DNA fragments fused to the 
Gal4 DBD [26]. The result of this screen was the realiza-
tion that approximately 1 % of all library sequences pos-
sess bona fide AD potential and that these sequences 
are significantly enriched with acidic residues. Later it 
was shown that hydrophobic amino acids are equally as 
important [27–30]. A similarly high percentage of ran-
dom sequences functioning as ADs and also having an 
excess of hydrophobic and acidic residues was identified 
in a completely different genetic context using HSF C-ter-
minal AD substitution by random yeast genomic DNA 
fragments [31] and in a screen using a completely artifi-
cial fusion library of LexA DBD connected to 45 nucle-
otides of randomized sequence [32]. The LexA-based 
screen also identified a small number of active sequences 
containing a total positive charge.
It is paradoxical that despite the easy functional inter-
changeability among ADs, even those belonging to tran-
scriptional activators from different phyla, they share no 
clear consensus sequence, and the only compositional 
similarity between different interchangeable ADs is an 
excess of hydrophobic and acidic amino acid residues. 
Even for this loose rule, there are known exceptions, 
with some ADs containing a positive total charge or at 
least an absence of acidic residues [32]. Functionality of 
polyglutamic acid or polyproline stretches has also been 
demonstrated [33]. Average frequency of functional AD 
sequences equal to ~1  % in randomized pools of DNA 
[26–28, 32] suggests astronomical number of func-
tional AD sequences, for instance equal to 1 % of 445 for 
a stretch of 45 nucleotides. The high variability of AD 
sequence compositions, in combination with very high 
frequency of functional AD sequences isolated from ran-
dom pools [26–28, 32], suggests low specificity of inter-
actions with potential targets.
AD sequence length
The lengths of ADs are another important characteristic. 
Natural AD length varies over several dozen amino acid 
intervals. Surprisingly, the above-mentioned screens of 
randomized sequences revealed that ADs with potency 
comparable to natural sequences can be as short as 
12, 11, nine, or even eight amino acids [26, 27]. In fact, 
natural AD sequences can generally be reduced in size 
to these functional minimums without significant loss 
of potency, although for some ADs it was shown that 
potency is proportionate to length [34]. Increasing AD 
length by fusing several AD modules in tandem increases 
the activity in an additive manner in some cases [35]. 
Demonstration of short peptides effectively function-
ing as ADs led to the formulation of a nine-amino-acid 
pattern prediction algorithm [21]. However, it has been 
shown that the results of applying this algorithm to well-
characterized Gcn4 or Gal4 sequences do not match the 
prediction [15].
Non‑natural ADs
The minimal size of functional ADs is not limited to eight 
amino acids, as it has been shown that the AD peptides 
can be substituted with non-natural compounds or other 
molecular sequences that are much smaller [13]. For 
instance, isoxazolidine (MW 290) can function in  vitro 
as an AD while chemically connected to LexA DBD, act-
ing with the same potency as the 14-amino-acid minimal 
module of VP16 natural AD (MW 1674) [13]. Several 
other similar compounds have also been demonstrated 
to function as ADs both in vivo and in vitro, displaying 
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functionality of compounds that are comparable in MW 
to two–three amino acids [13, 14, 36]. Importantly, 
these compounds have negatively charged and aromatic 
extremities. Similarly puzzling are demonstrations that 
natural ADs can be replaced in  vivo, with retention of 
functionality, by certain RNA sequences [37] or by the 
VP16 AD peptide chemically synthesized from non-nat-
ural D-amino acids mimicking the natural sequence [38].
Intrinsically disordered nature of ADs and structural 
adaptation upon target binding
Based on conservation of function between different AD 
sequences, it is logical to expect a conservation of spe-
cific structural motifs, as was clearly shown for DBDs [5, 
6]. Contrary to these expectations, ADs do not have spe-
cific structural motifs and are known to be a clear exam-
ple of intrinsically disordered protein domains, which is 
the subject of a new and rapidly developing research field 
[39–41]. Beginning with their discovery, AD sequences 
were believed to have an amphipathic helical structure [1, 
42]. Indeed, some structural studies of ADs in complex 
with proteins of the transcriptional machinery [43–45] 
have demonstrated ADs’ adaptation of the amphipathic 
helical structure in accordance with the “induced fit” 
model [46, 47]. This structural motif, although shown 
only in a limited number (˂15) of structural studies and 
only for AD–protein complexes [8], remains the only 
loosely defined structural feature of ADs other than the 
intrinsically disordered character.
In sum, despite being easily interchangeable, with 
conservation of function between activators belonging 
even to different biological phyla, as well as being eas-
ily isolatable in large numbers from random pools of 
sequences, ADs do not share any consensus sequence 
and/or structural motif, at least in the absence of their 
interaction partners. The size of ADs is also highly vari-
able, ranging from several dozen to as few as eight amino 
acid modules. Even the chemical nature is elusive, vary-
ing from different amino acids of L or D chirality work-
ing almost equally well, to certain RNA sequences, and 
to relatively small (MW 290) organic compounds. The 
paradox of conservation of function without conserva-
tion of sequence and/or structure shows the deficiency of 
our understanding of ADs and the necessity for further 
investigation, perhaps fundamentally revising research 
strategies and mechanistic concepts.
The commonalities arising from the investigation of a 
large number of natural and synthetic ADs are limited to 
the combination of acidity and hydrophobicity, and the 
intrinsically disordered nature of identified peptides. A 
large fraction of functional amino acid sequences (up to 
1  %) isolated from randomized pools suggests by itself 
that although some specificity is required, potentially 
interacting targets in vivo might be numerous, and inter-
actions are likely of low specificity.
Mechanism of AD function and overview of AD‑interacting 
targets in historical perspective
Since their discovery nearly three decades ago, the mech-
anism of ADs’ function was proposed to be a direct phys-
ical recruitment of transcription-related activities to gene 
promoters [1, 26, 48]. One of the initial and still standing 
hypotheses is that the direct interacting target of ADs is 
TATA box-binding protein (TBP) [49–53]. Subsequent 
experimental works showed that, in addition, other 
components of basal transcriptional machinery, such as 
TFIIB [54, 55], TFIIH [56, 57], TFIIA [58, 59], or RNA 
polymerase II itself [60], are likely targets of ADs. How-
ever, attempts to reconstitute this mechanistic model 
in vitro with purified components did not produce posi-
tive results [8], although this might be due to inadequate 
in vitro conditions.
A subsequent shift of attention in the transcription 
field to TBP-associated factors (TAFs) resulted in the 
proposition that the obligatory interacting targets of ADs 
are TAFs [61]. However, inactivation or depletion of indi-
vidual yeast TAFs, including the core TAFII that interacts 
with TBP, either did not compromise transcriptional acti-
vation or only affected it mildly [62, 63], and the affected 
genes were primarily cell cycle-specific genes.
An alternative school of thought [64, 65] that still 
stands [15, 66] is that the direct interacting targets of 
ADs are components of the large (at least 31-subunit) 
Mediator complex that may serve as a bridge between 
activators and RNA polymerase [67]. With the use of 
sophisticated biochemical and genetic experiments, sev-
eral subunits have been shown to be likely interacting 
targets of ADs: Med17 (Srb4), Srb10, Med15 (Gal11), 
Med2, and Med 25 [15, 66, 68–72]. The list is far from 
being exhaustive, especially if fungi, metazoan, and plant 
variants of Mediator complex are considered [66, 73–76]. 
Somewhat contradictory to the concept of direct recruit-
ment of Mediator complex by ADs was the demonstra-
tion of activator-independent function of Mediator in 
the activation of transcription [77]. These data again 
underscore the multiplicity of ADs’ potential targets and 
recruitment steps.
Explosive development in the 1990s and early 2000s 
of the field of chromatin-remodeling and histone-mod-
ifying activities, in combination with the demonstration 
of how critical some of these activities are for the initia-
tion of transcription [78–81], led to the identification of 
multiple AD-interacting targets among these protein 
complexes [82–85]. Convincing evidence obtained using 
both in vivo and in vitro approaches demonstrated Gal4 
and VP16 AD interactions with the SAGA complex via 
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subunit Tra1 [86–88], which is also an integral part of the 
NuA4 histone-modifying complex. Later, Tra1 was uti-
lized as a bait for the creation of a screening system for 
AD sequences [89]. Curiously, interactions of ADs with 
SAGA were also demonstrated via other subunits such as 
Ada2 and Taf17 (current nomenclature TAF9) [90–93]. 
The same ADs were shown to interact with the Swi1 and 
Snf5 subunits of the Swi/Snf chromatin-remodeling com-
plex [93–95]. Interestingly, the ADs’ interactions with the 
Snf2 subunit occurred within two distinct regions [95]. In 
higher eukaryotes, interaction of ADs was demonstrated 
with CBP, a multifunctional protein affecting not only 
histones but also components of transcriptional machin-
ery [96–98]. The list of AD-interacting targets described 
above is far from being complete and illustrates huge 
variations of possible targets and their combinations even 
within the chromatin-remodeling and histone-modifying 
group of enzymatic activities.
In an attempt to systematize and logically connect 
the recruitment events involved in chromatin remod-
eling, the yeast HO promoter was subjected to consecu-
tive chromatin immunoprecipitation experiments. The 
results were indicative of the ordered recruitment of 
activities. Chromatin remodeling by the SWI/SNF com-
plex was followed by recruitment of SAGA, which in turn 
facilitated Mediator and Pol II recruitment [99, 100]. But 
even within this model, the specifics of interactions are 
lacking, while physical and biochemical reasons for the 
specific order of recruitment events are not clear. The 
sequence of the recruitment events for the majority of 
other gene promoters has not been determined.
Perhaps the culmination of this line of investigation, 
demonstrating a wide range of possible mechanisms and 
synergistic interactions on long- and short-range scales, 
is a recent attempt to investigate the functionality of 223 
chimeric activators created by fusion of individual subu-
nits of known chromatin regulators to zinc finger DNA-
binding proteins [2]. Although it did not reveal a single 
specific mechanism or order of recruitment events, this 
study demonstrated an enormous scale of possible 
recruitment combinations. This immense complexity 
demands clarification and mechanistic insight.
In an initial attempt to unite this multiplicity of possi-
ble interacting targets in a uniform mechanism, the acidic 
ADs were proposed to function as “acidic blobs” recruit-
ing numerous protein complexes by simple electrostatic 
interactions [101, 102]. This view later was significantly 
revised, and, according to a new model, interactions of 
ADs with multiple targets are bi-phasic, with the initial 
binding phase being fast and nonspecific, based on the 
electrostatic interactions, and the following phase being 
slower, entropy-driven, and involving activator–target-
induced fit [103]. This model is based on in vitro surface 
plasmon resonance studies and was tested for several 
possible targets, including TBP, Swi1, and Snf5.
More recent investigation of GCN4–Mediator interac-
tions [15], based on both in vivo and in vitro approaches 
and involving extensive mutagenesis, led to postulation 
of a model based on “fuzzy” interactions. This study also 
confirmed that AD–target interactions do not depend 
on any one residue within the GCN4 AD and likely are 
based on multiple potentially redundant contacts. Con-
firming the challenges related to investigation of ADs, 
this study once again revealed that after three decades of 
intensive investigations, we are still not entirely clear on 
understanding the exact mechanism of ADs’ function.
Specificity challenge: recruitment of large numbers 
of potential targets via low‑specificity interactions
Summarizing ADs’ properties, interacting targets, and 
the mechanism of AD function, it is evident that despite 
enormous efforts over a long period of time, there is 
no clear mechanistic understanding of ADs’ function. 
Although each specific AD performs essentially the same 
function, namely facilitating chromatin remodeling in 
broad sense and assembly of the transcription initia-
tion complex, ADs do not have a consensus sequence. 
That is true even for synthetic ADs selected for func-
tioning within the context of the same activator and the 
same reporter gene(s) [26, 31, 32]. The chemical nature 
of ADs can vary from amino acid sequences to specific 
RNA sequences, and even to specific non-natural chemi-
cal compounds. Structurally, AD sequences are largely 
disordered, with some indications of more stable struc-
ture adaptation upon interaction with a target. The spec-
trum of potential targets is vast, and the mechanism of 
these interactions, as well as the nature of prioritizing 
these interactions, is not clear. Utilizing the current and 
commonly accepted direct-recruitment model for AD 
function leads to the formulation of a number of “hard to 
explain” questions [3, 8, 15, 16]:
1. Considering that ADs interact with targets utilizing 
nonspecific, low-affinity “fuzzy” interactions with 
very few contact points (two–three critical amino 
acids within 10–12 amino acid blocks or even rela-
tively simple compounds [13, 21]), it is not clear how 
or whether a specific AD sorts through and chooses 
the right interacting target among hundreds of 
potential targets. This is even more puzzling consid-
ering, on the one hand, the low abundance of most 
of the possible targets in the cell nucleus, and on the 
other, the competition of possible interacting targets 
with each other, possibly making each individual 
interaction either insignificant or functionally disrup-
tive.
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2. If the best target exists for a specific activator in the 
context of a specific promoter (as it was suggested 
for GCN4-Gal11 or CBP-TBP pairs), why does the 
experimental selection of functional ADs from a pool 
of random sequences or the evolutionary selection 
not yield a specific AD consensus sequence? Or simi-
larly, why is there a lack of sequence conservation 
among ADs?
3. What determines the sequence of recruitment events 
of seemingly distinct enzymatic complexes to the 
gene promoter, and how are ADs involved in this 
process?
4. The structural analysis of AD sequences certainly 
reveals the absence of a clear motif. In fact, ADs 
comprise one of the best examples of intrinsically 
disordered protein domains. Why is the structural 
disorder apparently so important for ADs’ function?
5. Why does the same AD retain functionality and 
often the degree of activation potential if transferred 
within evolutionarily very distant contexts of mam-
malian, plant, and fungi cells [1, 18–22]?
One can invoke the direct-recruitment model to argue 
that the high level of randomness of sequence and struc-
ture is exactly necessary for the recruitment of multiple 
targets from a large pool, but this does not help with 
resolving the first three questions. Challenges regard-
ing understanding the mechanism of ADs’ function have 
been stated on multiple occasions [3, 8, 15, 16]. The long-
standing questions and absence of clear mechanistic 
explanation for ADs’ function suggest the necessity for a 
revision or at least for flexibility in consideration of cur-
rent mechanistic concepts of ADs’ function.
AD–nucleosome interactions as an alternative addition 
to direct‑recruitment model
In an attempt to help with solving problems formulated 
above, we propose to consider additional mechanistic 
options that involve local interaction of ADs with pro-
moter nucleosomes. This possibility naturally arises from 
the fact that a majority of ADs are negatively charged 
and hydrophobic, thus likely interacting with positively 
charged and hydrophobic targets. Another premise 
for our model is that general chromatin remodeling at 
gene promoters is a well-established and often required 
step leading to an activation of transcription. Accord-
ing to the AD–nucleosome interaction model, the oth-
erwise unlikely and weakly interacting partners—ADs 
and nucleosomes—are brought into proximity by the 
DBD of the activator and interact only in the vicinity of 
the activator-binding site due to this facilitation by DBD. 
Interactions of ADs are likely possible at multiple points 
on nucleosomes and, while being of low specificity, are 
leading to a structural destabilization of promoter nucle-
osomes, and either to a translocation of nucleosomes 
from the promoter, or to an exposure for the chromatin 
remodelers and histone modifiers triggering additional 
chromatin-remodeling events. ADs, which remain at the 
nucleosome-free promoter anchored by DBD, later par-
ticipate in direct recruitment and more importantly sta-
bilization of transcription initiation complex. Thus, ADs 
may play a dual function of initially triggering nucleo-
some distortion and translocation, and later attracting 
and stabilizing transcription initiation complex (Fig. 1).
There are significant distinctions in the interaction of 
ADs (with interaction partners) in the direct-recruitment 
model and in the nucleosome-distortion model. For the 
recruitment model, the requirement is an establishment 
of a functional link by attraction of a specific enzymatic 
activity(s) to the promoter; thus, the more functionally 
productive interactions have to have higher affinity to 
specific targets interacting in a specific structural region 
of the target as it was demonstrated for TBP, Gal11, Tra1, 
and others [15, 87, 104, 105]. In contrast, for the nucle-
osome-distortion model, in order to avoid nucleosome 
stabilization at the promoter (as this outcome impedes 
transcription initiation), the interactions must be of low 
or very low affinity, occurring likely in multiple struc-
tural points of the nucleosome with these points compet-
ing with each other and preventing creation of a stable 
link and thus maximally destabilizing the nucleosome. 
Importantly, these interactions are transient, significantly 
facilitated by DBD of the activator, and thus possible only 
in the vicinity of the activator-binding site. The func-
tion of AD in the nucleosome-distortion model can be 
compared to the function of a mild DBD-directed deter-
gent that partially dissolves promoter nucleosomes. The 
nucleosome-distortion model thus is highly compatible 
with the absence of a clear consensus sequence in ADs as 
well as with intrinsic structural disorder of ADs.
Invoking AD–nucleosome interaction model provides 
solutions to all of the questions raised above:
1. Low-affinity “fuzzy” interactions, instead of creating 
a conundrum of mutually disruptive and competitive 
recruitment events of co-activators [2], are actually 
an important and unavoidable requirement of the 
AD–nucleosome-distortion model.
2. Considering the requirement of low- or very low-
specificity destabilizing interactions in multiple 
points of nucleosomes, it is clear why selection of 
functional ADs from random pools [26, 31, 32] has 
never been shown to produce a specific AD consen-
sus sequence. The same reasoning can be applied to 
answering the question of why selection of native 
ADs during actual biological evolution led to such 
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great variability and absence of a consensus sequence 
in ADs.
3. As a result of AD–promoter nucleosome interac-
tions, the recruitment of distinct enzymatic activities 
to a specific gene promoter can be dictated, at least 
in some situations, by the chromatin architecture 
of a specific promoter and by a specific nucleosome 
distortion induced by a specific AD. An additional 
source of specificity could be the particular composi-
tion of promoter DNA elements, such as in TATA- 
and TATA-less promoters.
4. The intrinsically disordered structural nature of ADs 
is a feature compatible with and actually favorable 
for “fuzzy” interactions with different destabilizing 
points of nucleosomes leading to the subsequent 
recruitment of co-activators.
5. Finally, the retention of functionality of ADs dur-
ing the transfer of the same sequence between very 
distant biological phyla is also easily explainable by 
extremely high evolutionary conservation of histones 
and nucleosome structure. In contrast, the evolution-
ary conservation of co-activator complexes is sig-
nificantly lower. Consequently, for the direct-recruit-
ment model, this would dictate a significant drop of 
the AD activation potential during transfer into an 
evolutionarily distant species.
The proposition of the nucleosome-distortion model 
can be supported by the following considerations. First, 
Direct co-acvator recruitment
Promoter nucleosome distoron 
followed by co-acvator recruitment
Pol II
mRNA
Pol IIMediator
TBP
TFIID
TFIIB
TFIIA
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NuA3NuA4
Ino80
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b
Fig. 1 Traditional model of direct co-activator recruitment and an alternative model postulating initial promoter nucleosome distortion followed 
by co-activators and basal factors recruitment and assembly of transcription initiation complex. a The direct-recruitment model suggests numer-
ous physical interaction of AD with multiple co-activators and transcription initiation complex components, thus bringing them to the promoter. b 
In the promoter nucleosome-distortion model, the AD modifies promoter nucleosome structure triggering an action of enzymatic activities, thus 
further affecting nucleosome structure, which leads to the nucleosome translocation and promoter opening. After this stage, the AD in cooperation 
with freely exposed DNA promoter elements recruits and stabilizes at the promoter the transcription initiation complex components
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the abundance of histones in the cell is at least one to 
two orders of magnitude higher than the abundance of 
any interacting targets of ADs [106] described above, and 
nucleosomes are present at almost any gene promoter. 
Considering that histones are predominantly nuclear 
proteins, the ratio for histones is even greater and may 
exceed three orders of magnitude in the nucleus. Sec-
ond, taking into account that the initial stage of AD–tar-
get interactions might be nonspecific charge scanning 
[15, 103], it is logical to compare the exposure of posi-
tive charges on the surface of nucleosome and frequently 
considered AD recruitment targets. While nucleo-
some (PDB ID 3AFA) has 134 solvent-exposed posi-
tively charged (lysine and arginine) amino acid residues, 
GAL11 (Med15) has 111 total positive charges (no struc-
ture available), and TBP (PDB ID 1CDW) has only 32. 
Considering that a nucleosome usually is positioned in 
the vicinity of the activator-binding site at the promoter, 
while the co-activator targets are not, the initial charge 
scanning by AD happens more likely on the nucleosome 
surface.
There are many ways the nucleosome structure can be 
disturbed; however, for nucleosome relocation, at least 
some of the histone–DNA contacts must first be broken. 
Considering that AD sequences typically can be reduced 
to eight or nine amino acids [21, 27] or even smaller 
functional blocks [13] and that the critical residues in 
ADs are negatively charged and highly hydrophobic (usu-
ally aromatic) [26, 27, 31, 32], the simplest way to distort 
the histone–DNA contacts would be by interaction of 
ADs with positively charged lysine or arginine residues 
of histones and aromatic bases of DNA [107], perhaps by 
intercalation. The average distance between the histone 
octamer surface amino groups of arginines or lysines 
to the closest DNA base (human nucleosome PDB ID 
3afa) lies between four and 16 Å, with the average being 
between 10 and 12 Å. Considering that one amino acid in 
the extended conformation covers approximately 3.5 Å, 
these distance intervals are in good agreement with the 
typical AD length [21, 26, 27, 31, 32].
Fundamental difficulties of detecting AD–nucleosome 
interactions
The in  vivo possibility of AD–nucleosome interactions 
was demonstrated in early experiments. By modified 
yeast two-hybrid screening, it was shown that histone H3 
is among possible targets of such transcriptional activa-
tors as human CTF1/NF1 [108] and yeast Hap1 [109]. It 
was demonstrated also that the histone-binding module 
of mouse HNF3 is important for function of this activa-
tor [110]. For the CTF1/NF1 activator, the histone H3 
interacting module was pinpointed to a 14-amino-acid 
stretch, and it was demonstrated that the splice variants 
that lack this sequence lose the transcription activation 
potential [111, 112]. Importantly, the histone H3-binding 
peptide is able to function as a synthetic AD while fused 
to DBD of either GAL4 or as a part of HSF1 [31].
These early experiments demonstrating the possibil-
ity of AD–nucleosome interactions, in comparison with 
the demonstration of direct recruitment of co-activators, 
are certainly not numerous, and critics may ask why. The 
answer might lie in the nature of the AD–nucleosomal 
contacts postulated by the AD nucleosome-distortion 
model. Considering this model, the challenges of dem-
onstration of AD–nucleosome interactions become 
obvious:
1. These interactions are transient and of very low 
specificity, possible only with facilitation by the acti-
vator’s DBD and only to nucleosomes in close prox-
imity of the activator-binding site. This extremely 
low-specificity requirement directly originates from 
experimental data showing high randomness of AD 
sequences (1–2 % of random pools), which are able to 
substitute the native ADs [26, 31, 32]. One percent-
age of a random pool as well as short size of typically 
10–15 amino acids with only few critical ones sug-
gests interactions of extremely low specificity at the 
level of noise. These kinds of interactions in classical 
biochemical experiments (pull-downs, cross-linking, 
etc.) are considered as nonessential and are typically 
ignored or eliminated by experimental procedures as 
background or noise.
2. AD interactions with nucleosomes likely occur at 
multiple low-affinity points which compete with each 
other. Contrary to the proposed model, any high-
affinity interactions would lead to nucleosome stabi-
lization and repression of transcription. The idea that 
ADs interact with nucleosomes at multiple compet-
ing points is also compatible with the multiplicity of 
AD sequences that can function in identical molecu-
lar contexts [26, 31, 32]. The fact that a majority of 
ADs are intrinsically disordered also supports this 
supposition. However, the detection of these tran-
sient, low-specificity interactions occurring in multi-
ple points of the target is challenging even for such 
sensitive and tolerant to high Kd method as NMR.
3. The distorting interactions of AD with nucleosomes 
are likely less strong and specific than with co-acti-
vators and transcriptional PIC components. Thus, in 
typical biochemical experiments, they are likely to be 
ignored, leaving interactions with co-activators and 
PIC as the dominant ones and thus more obvious for 
mechanistic interpretations of AD function.
4. The difficulties with explaining the mechanisms 
of AD function [3, 8, 15, 16], which persist despite 
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enormous experimental efforts for more than three 
decades, can well be rooted in conceptual fixation 
on relatively strong physically connecting and spe-
cific co-activator recruitment interactions, as well as 
in the methodological ease of detection and experi-
mental manipulation of these interactions. The long-
standing experimental and conceptual challenges 
with mechanisms of AD function are typical for the 
whole newly emerging field of intrinsically disordered 
protein regions. This field became prominent only 
recently, after the realization that a majority of pro-
tein regions in higher eukaryotes contain parts that 
are intrinsically disordered, or at least not locked into 
rigid structures; however, this disorder and random-
ness are more prominent in vivo and often required 
for proper function [41]. Designing of experiments 
directly demonstrating and proving functionality 
of low-specificity interactions at the noise level is a 
formidable challenge for classical biochemistry and 
might require fundamental reevaluation of methodo-
logical approaches.
Conclusions
The function of ADs has been a fundamental enigma of 
the transcription regulation field for more than 30 years. 
One of the reasons we face this problem arguably is due 
to the traditional approach, which considers vital pro-
tein–protein interactions in terms of the key-and-lock 
concept or an approximation of it, looking for specific 
or semi-specific interactions between AD and possible 
target(s), and utilizing classical biochemistry methods 
designed to detect these specific interactions and discard 
noisy background. Our review and analysis is an attempt 
to get away from this stereotype, and to switch to a real-
ity of intrinsically disordered regions functioning at an 
extremely low-specificity level. The model of transcrip-
tion activation based on promoter nucleosome distortion 
by AD requires these extremely low-affinity noise-level 
interactions and is an addition to the classical direct-
recruitment model (Fig. 1). Our proposed model resolves 
the AD sequence specificity problem, as well as associ-
ated problems with AD target selection. The extremely 
low specificity of AD–target interactions at the biochem-
ical noise level, akin to the action of a mild detergent, 
underscores the fundamental challenges associated with 
experimental proof of the model and requires reevalua-
tion of classical methodological approaches.
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